0 TSX News - December 2, 2024TC Energy provides conversion right and dividend rate notice for Series 1 and 2 preferred sharesCALGARY, Alberta, Dec. 02, 2024 (GLOBE NEWSWIRE) — News Release – TC Energy Corporation (TSX:TRP) (NYSE:TRP) (TC Energy) today announced […]Read More
0 NASDAQ Companies - December 2, 2024Lotus Technology Announces Delivery Updates of First Eleven Months of 2024NEW YORK, Dec. 02, 2024 (GLOBE NEWSWIRE) — Lotus Technology Inc. (“Lotus” or the “Company”), a leading global intelligent and […]Read More
0 TSX Venture News - December 2, 2024Azincourt Energy Grants RSUsVANCOUVER, British Columbia, Dec. 02, 2024 (GLOBE NEWSWIRE) — AZINCOURT ENERGY CORP. (“Azincourt” or the “Company”) (TSX.V: AAZ, OTC: AZURF), […]Read More
0 TSX Venture News - December 2, 2024Fountain Asset Corp. Closes Share for Debt TransactionTORONTO, Dec. 02, 2024 (GLOBE NEWSWIRE) — FOUNTAIN ASSET CORP. (TSXV: FA) (the “Company”) is pleased to announce that it […]Read More
0 TSX News - December 2, 2024Bombardier Confirms Reaching Settlement in Legal Dispute with HoneywellMONTRÉAL, Dec. 02, 2024 (GLOBE NEWSWIRE) — Bombardier Inc. (“Bombardier”) today confirmed that it has reached an agreement to settle […]Read More
0 NASDAQ Companies - December 2, 2024UPDATE — nCino to Participate in Upcoming Investor ConferencesWILMINGTON, N.C., Dec. 02, 2024 (GLOBE NEWSWIRE) — nCino, Inc. (NASDAQ: NCNO), the leading provider of intelligent, best-in-class banking solutions, today […]Read More
0 NYSE Companies - December 2, 2024BIP Investment Corporation Announces Results of Special Meeting and Intention to Redeem Series 1 Preferred SharesBROOKFIELD, NEWS, Dec. 02, 2024 (GLOBE NEWSWIRE) — BIP Investment Corporation (“BIPIC”) (TSX: BIK.PR.A), an indirect subsidiary of Brookfield Infrastructure […]Read More
0 NASDAQ Companies - December 2, 2024Revolution Medicines Announces Commencement of Public Offering of Common StockREDWOOD CITY, Calif., Dec. 02, 2024 (GLOBE NEWSWIRE) — Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted […]Read More
0 NASDAQ Companies - December 2, 2024Jasper Therapeutics Announces First Patient Dosed in Phase 1b/2a ETESIAN Clinical Study of Briquilimab in AsthmaREDWOOD CITY, Calif., Dec. 02, 2024 (GLOBE NEWSWIRE) — Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a clinical stage biotechnology company […]Read More
0 NASDAQ Companies - December 2, 2024Information regarding the total number of voting rights and total number of shares of the Company as of November 30, 2024Information regarding the total number of voting rights and total number of shares of the Company as of November 30, 2024 […]Read More